Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Blueprint Medicines Corp | Director | Common Stock | 8.74K | $919K | $105.13 | Jun 12, 2024 | Direct |
Aerovate Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 12.5K | $205K | $16.37 | Jun 5, 2024 | Direct |
Day One Biopharmaceuticals, Inc. | Director | Stock Option (right to buy Common Stock) | 32.3K | May 23, 2024 | Direct | ||
PepGen Inc. | Director | Stock Option (Right to Buy) | 13K | Jun 20, 2024 | Direct | ||
Blueprint Medicines Corp | Director | Stock Option (Right to Buy) | 4.57K | Jun 12, 2024 | Direct | ||
ACCELERON PHARMA INC | CEO and President, Director | Common Stock | 0 | $29.37 | Nov 19, 2021 | Direct | |
ACCELERON PHARMA INC | CEO and President, Director | Option to Purchase Common Stock | 0 | Nov 19, 2021 | Direct | ||
ALBIREO PHARMA, INC. | Director | Stock Options (Right to Buy) | 0 | Mar 2, 2023 | Direct |